Scientists are pushing the limits of CAR T-cell therapy, a treatment where a patient’s immune cells get rebuilt to hunt down disease. Right now, it works well against certain blood cancers but struggles with solid tumors and autoimmune conditions. Why? The cells often pick the wrong targets, fail to
The heart never stops. Every second of every day, it pumps blood through miles of vessels, pushing against high pressure to keep the body alive. This relentless mechanical work turns the heart into a tough environment for cancer cells. While cancer spreads easily to organs like the lungs or liver, i
In 2023, seven leading economies made a quiet vow to join forces against some of the toughest cancers. Australia, Canada, France, Germany, Japan, the UK and the US promised to share knowledge and speed up care for cancers where survival rates are often low. The challenge they faced wasn’t just medic
Pancreatic cancer is one of the most lethal cancers in the United States, killing more than 50, 000 people each year. The disease is tough to treat and most patients die within a year of diagnosis, with only a small fraction surviving five years. Recently, two experimental drugs have entered clin
After surgery, patients with advanced esophageal cancer often face the risk of the disease coming back. A recent real‑world study examined how well a drug called nivolumab, given after surgery, can predict who might see the cancer return. The researchers looked at a group of people who had their tum
The link between long‑term gut inflammation and colorectal cancer is clear, but the focus has usually been on DNA changes in the lining cells. Recent research shows that the surrounding support cells, called fibroblasts, play a much bigger part than previously thought. These cells build the structur
A local man began tracking cancer cases on his old street, noticing a disturbing pattern. He marked each affected home with an X and eventually mapped 28 cases on First Street alone, plus another 41 across the town. The numbers sparked alarm among residents and health experts who said the rate se
Pharmaceutical giant Eli Lilly just dropped $3. 25 billion upfront on a startup called Kelonia Therapeutics, with the potential to pay $7 billion total if everything goes right. The big idea? A treatment that turns your own immune cells into cancer fighters without the usual lab work. Instead of yan
At the latest cancer research conference, experts shared updates on three major topics: a cutting-edge treatment from China now owned by Merck, a bold experiment with CAR-T therapy, and the uneven access to cancer care across the U. S. The event also offered ways for people to join in, including a l
When prostate cancer is first detected, doctors often classify it as "clinically insignificant. " This means it's slow-growing and might not need immediate treatment. But in some cases, a closer look reveals the cancer is actually more aggressive than it seemed at first. That’s where advanced imagin
